According to a study, incretin mimetics reduce the cancer risk in obese patients.

14 types of tumors examined According to a study, incretin mimetics reduce the cancer risk in obese patients.

Incretin mimetics are now used not only to treat type 2 diabetes, but also to reduce weight in obese patients. A study investigated the implications of this for the cancer risk of those affected.